home / press / releases

Menu
  • Search all tables

releases: https://hankjohnson.house.gov/media-center/press-releases/rep-johnson-introduces-resolution-increase-awareness-rare-cancer

One row per release. Full-text search runs over title + body text.

Data license: MIT · Data source: dwillis/congress-press

This data as json

url title date year month party chamber state member_name bioguide_id domain scraper source date_source text has_text collected_at updated_at
https://hankjohnson.house.gov/media-center/press-releases/rep-johnson-introduces-resolution-increase-awareness-rare-cancer Rep. Johnson Introduces Resolution to Increase Awareness of Rare Cancer, Chordoma 2022-12-13 2022 2022-12 Democrat House GA Henry C. "Hank" Johnson, Jr. J000288 hankjohnson.house.gov hankjohnson https://hankjohnson.house.gov/media-center/press-releases scraper WASHINGTON, D.C. — Congressman Hank Johnson (GA-04) announced today that he introduced a resolution to raise awareness of a rare form of cancer called chordoma after a member of his staff was diagnosed with the rare condition earlier this year. [Watch the Congressman’s floor speech HERE] Classified as a rare cancer of the spine and skull, chordoma is diagnosed in just 1,000 people worldwide every year, 300 of whom are in the United States. “Earlier this year a member of my staff, Joshua Smith, was diagnosed with chordoma,” said Rep. Johnson. “While he is currently recovering and back at work, it is essential that we shed light on chordoma and rare cancers that impact members of our family – our personal families and work families.” Chordomas are among the most complicated tumors to treat because they are located in the brain stem, spinal cord, and important nerves and arteries around the brain stem. No treatments are known to cure or effectively control the disease, which today consists of surgeries and radiation. The resolution seeks to lift up chordoma patients and families need to increase funding and support for accurate and early diagnosis, the development of new treatments, diagnostics, and cures, fewer hurdles between research and new treatments; and patient-centric approaches to drug discovery and development. Read the resolution HERE. 1 2026-03-30T01:40:41Z 2026-04-08T03:32:05Z
Powered by Datasette · Queries took 0.706ms · Data license: MIT · Data source: dwillis/congress-press